Foundation president, Harvey Fineberg, and chairman emeritus and co-founder, Gordon Moore, discuss the Statement of Founders’ Intent with staff.
To support the development of a set of clinical quality measures to improve the performance of breast cancer screening tests.
Thank you for sharing.
Acumen
$603,163
18 months
Improving the Diagnostic Performance of Screening Tests for Breast Cancer
Jul 2022
Creating positive outcomes for future generations.
